Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Call for Application for 2020 Tsinghua Amgen Scholars Program 2020-01-15 18:18
AXA Hong Kong launches the first 'AXA Chronic Disease Management Programme' 2020-01-15 15:41
Europ Assistance opens new office in Thailand 2020-01-15 09:00
Medit Responds to Ongoing Patent Infringement Lawsuit in Germany 2020-01-14 23:26
ZAP Surgical Brain Tumor Treatments Commence at PLA General Hospital 301 in Beijing, China 2020-01-14 23:07
Innovent Out-Licenses Commercial Rights for Avastin® Biosimilar to Coherus BioSciences in the United States and Canada 2020-01-14 08:00
Genome & Company announces a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer 2020-01-14 08:00
Evolution 2.0 Prize: Unprecedented $10 Million Offered To Replicate Cellular Evolution 2020-01-14 03:23
Mentice Showcases First-of-Its-Kind Flexible Coronary Training Solution at IMSH 2020 2020-01-14 03:15
WuXi Advanced Therapies Launches New World-Class AAV Vector Suspension Platform 2020-01-13 22:00
Volition Develops a New Improved Nu.Q™ Assay Format 2020-01-13 22:00
EW Nutrition Launches Revolutionary Enzyme in India 2020-01-13 21:22
COMPASS Pathways Granted Patent Covering Use of Its Psilocybin Formulation in Addressing Treatment-resistant Depression 2020-01-13 19:05
111, Inc. Enters Into Strategic Partnership with Bestyoo to Upgrade Online Healthcare Service Model 2020-01-13 18:30
Discover the Latest Information and Seize Market Opportunities in the Annual Event of the CRO & CMO Industry at ICSE China 2020 2020-01-13 17:34
Rise in Pharmaceutical Applications to Foster Demand for Mass Spectrometers in Europe 2020-01-13 16:02
Exonate Announces Collaboration With Janssen to Develop a New Eye Drop for the Treatment of Retinal Vascular Diseases Including Wet Age-related Macular degeneration (AMD) and Diabetic Macular Oedema (DMO) 2020-01-13 16:00
Nanoform Appoints Head of US Sales 2020-01-13 15:21
Tyvyt (Sintilimab Injection) Combined with ALIMTA (Pemetrexed) and Platinum Met Predefined Primary Endpoint in Phase 3 ORIENT-11 Study as First-Line Therapy in Nonsquamous NSCLC 2020-01-13 12:42
Elevating Ideas with Hilton in Malaysia 2020-01-13 10:10
1 849 850 851 852 853 1612